This pilot study will test some exciting new interactive features that ECOG-ACRIN would like to add to the surveys and questionnaires used to evaluate the experiences of young patients
This trial is for patients who have cancer cells still in the blood or bone marrow after approximately one year of lenalidomide maintenance therapy following a stem cell transplant